GSA Capital Partners »

Aardvark Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $472k 36k 13.14

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Millennium Management
Silverarc Capital Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Centiva Capital
Cantor Fitzgerald, L. P.
Northern Trust
Superstring Capital Management
Goldman Sachs Group

View all funds holding Aardvark Therapeutics